The company has set ambitious goals of declaring new development candidates for hematopoietic stem cell (HSC) and liver editing by mid-2025, and aims to achieve key milestones such as submitting ...

(Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced its three-year strategic priorities, anticipated 2025 key ...

Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.

Achieved proof of concept in non-human primates validating high efficiency gene editing in the liver with first use of AsCas12a delivery by LNP. Demonstrated proof of upregulation strategy in mice ...

The Maharashtra State Board of Secondary and Higher Secondary Education (MSBSHSE) has issued hall tickets for the HSC Board Exam 2025. Schools must print and distribute admit cards without ...

Liver morphology and fibrosis were evaluated using hematoxylin-eosin (H&E ... Hospital of Chengdu University of Traditional Chinese Medicine approved the study design with approval number 2024DL-001.

Cirrhosis is the severe scarring or fibrosis of the liver. It happens in the late stage of liver disease and other conditions that involve liver damage. The scarring that occurs with cirrhosis is ...

Private coaching colleges are claiming to have taught hundreds of HSC high-achievers, including almost a quarter of students who scored top marks in the toughest maths course last year.

Results: The results showed that AURKA was positively correlated with the progression of liver fibrosis and was predominantly expressed in activated HSCs. Silencing AURKA inhibited HSC activation and ...

1 Liver Research Laboratory, University of Crete School of Medicine ... The aim of this study is to investigate the role of somatostatinergic and cytokine signalling in hepatic stellate cells (HSC), ...